FDA.reportPublic FDA data

netupitant 300 MG / palonosetron 0.5 MG Oral Capsule

RxCUI
1552343
RxNorm name
netupitant 300 MG / palonosetron 0.5 MG Oral Capsule
Display name
netupitant 300 MG / palonosetron 0.5 MG Oral Capsule
Full name
netupitant 300 MG / palonosetron 0.5 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AKYNZEONETUPITANT AND PALONOSETRONHelsinn Therapeutics (U.S.), Inc.8e47618e-af46-4d82-94e8-1507c042252d2026-06-23Warnings, Adverse reactionsExact identifier
rxcui: 1552343

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
8e47618e-af46-4d82-94e8-1507c042252dnetupitant 300 MG / palonosetron 0.5 MG Oral CapsulePSN18These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 201820260126
8e47618e-af46-4d82-94e8-1507c042252dnetupitant 300 MG / palonosetron 0.5 MG Oral CapsuleSCD18These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 201820260126
8e47618e-af46-4d82-94e8-1507c042252dnetupitant 300 MG / palonosetron 0.5 MG (as palonosetron hydrochloride 0.56 MG) Oral CapsuleSY18These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 201820260126